Mal-VC-PAB-PNP-CDN-A
Mal-VC-PAB-PNP-CDN-A is a drug-Linker conjugates for ADC[1].
Product Specifications
CAS Number
2640880-35-7
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mal-vc-pab-pnp-cdn-a.html
Solubility
10 mM in DMSO
Smiles
CC(C)[C@H](NC(CCCCCN1C(C=CC1=O)=O)=O)C(N[C@H](C(NC(C=C2)=CC=C2COC(NCC[C@@H]([C@@H](O3)[C@@H]4N5C=NC6=C5N=C(N)NC6=O)[C@H](O4)COP(O[C@H]7[C@@H](O)[C@H](N(C=N8)C9=C8C(N)=NC=N9)O[C@@H]7COP3(O)=O)(O)=O)=O)=O)CCCNC(N)=O)=O
Molecular Formula
C51H67N17O20P2
Molecular Weight
1300.13
References & Citations
[1]Chen, Zhijian, et al. ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN IMMUNOTHERAPY. Patent. US20210015941A1.|[2]Wang Y, et al. Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29 (1) :754-766.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941176-500 1x 500 µL
EMI1 (EMI1/1176), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682167-500 1x 500 µL
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 